Skip to content
★ Sign in to follow
RR

Richard Rudolph

Cyberonics Inc
Total declarations
14
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€275k

Latest filing published 04 Jun 2007 for CYBERONICS INC, €35k.

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

No signal scores available.

Richard Rudolph: trading record in brief

Richard Rudolph is a declared insider of Cyberonics Inc, with filings sourced from SEC (Form 4). In total, 14 filings cover trades dated from 1 June 2006 to 1 June 2007.

No open-market purchase appears, only 14 sales worth €275k. Since January 2007: no purchases and 1 sale on the market.

The latest filing, published on 4 June 2007, reports an open-market sale of €35k in Cyberonics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Richard Rudolph

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    46,775 USD0SEC
    2,500 shares@ US$18.71Common StockSEC:0001209191-07-034887:0
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    60,600 USD0SEC
    3,000 shares@ US$20.20Common StockSEC:0001209191-06-042473:0
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    12,126 USD0SEC
    600 shares@ US$20.21Common StockSEC:0001209191-06-042473:1
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    2,022 USD0SEC
    100 shares@ US$20.22Common StockSEC:0001209191-06-042473:2
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    6,069 USD0SEC
    300 shares@ US$20.23Common StockSEC:0001209191-06-042473:3
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    1,587 USD0SEC
    78 shares@ US$20.34Common StockSEC:0001209191-06-042473:4
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    8,140 USD0SEC
    400 shares@ US$20.35Common StockSEC:0001209191-06-042473:5
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    1,323 USD0SEC
    65 shares@ US$20.36Common StockSEC:0001209191-06-042473:6
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    4,080 USD0SEC
    200 shares@ US$20.40Common StockSEC:0001209191-06-042473:7
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    5,925 USD0SEC
    290 shares@ US$20.43Common StockSEC:0001209191-06-042473:8
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    136,948 USD0SEC
    6,700 shares@ US$20.44Common StockSEC:0001209191-06-042473:9
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    4,090 USD0SEC
    200 shares@ US$20.45Common StockSEC:0001209191-06-042473:10
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    59,088 USD0SEC
    2,400 shares@ US$24.62Common StockSEC:0001209191-06-034294:0
  • ▼
    VP, Clinical & Medical AffairsExecutivesCyberonics Inc
    2,463 USD0SEC
    100 shares@ US$24.63Common StockSEC:0001209191-06-034294:1

14 of 14 declarations